CLINICAL_TRIALS
trial_result
· 2014-09-25
Clinical Trial Update: A Study of Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer [Phase 2]
Summary
A Phase 2 trial of trastuzumab (Herceptin) as monotherapy for metastatic urothelial cancer was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Urinary Tract Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-09-25